NERLYNX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 20 Feb 2024)
What this means for you
Registered since 17 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86678985
- Registration number
- 5311871
- Mark type
- Stylized text
- Filed
- 30 Jun 2015
- Published for opposition
- 17 Nov 2015
- Registered
- 17 Oct 2017
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer
Owner
- Puma Biotechnology Inc., Los Angeles, CA, US
- Puma Biotechnology Inc., Los Angeles, CA, US
- Puma Biotechnology Inc., Los Angeles, CA, US
Prosecution history
- 20 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Sept 2023 — TEAS SECTION 8 & 15 RECEIVED
- 17 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Aug 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 17 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 12 Sept 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Sept 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Aug 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2017 — USE AMENDMENT FILED
- 18 Aug 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jul 2017 — TEAS STATEMENT OF USE RECEIVED
- 12 Jul 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jul 2017 — SOU EXTENSION 3 GRANTED